Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.51 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | EGFR | P00533 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7919294 | 0.91 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL7924119 | 0.89 | ALDH1A1 (0.64) | ALDH1A1LMNAHTTMEN1KMT2A | |
| SCHEMBL7918939 | 0.88 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL7924012 | 0.88 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL7924123 | 0.88 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL8442903 | 0.88 | ALDH1A1 (0.55) | ALDH1A1LMNAHTTMEN1KMT2A | |
| SCHEMBL7919288 | 0.86 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL7919333 | 0.85 | MEN1 (0.54) | ALDH1A1LMNAHTTMEN1KMT2A | |
| SCHEMBL7918922 | 0.81 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL7921017 | 0.81 | ALDH1A1 (0.60) | ALDH1A1LMNAHTTKMT2AMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0811375-B1 | GLUTAMIC ACID RECEPTOR AGONIST | NIPPON SUISAN KAISHA LTD (JP) | 2001-01-03 | — | — | EP | disclosed |
| US-5955505-A | TREATING NERVE DEGENERATIVE DISORDERS | NIPPON SUISAN KAISHA, LTD. (JP) | 1999-09-21 | — | — | US | disclosed |
| EP-0811375-A1 | GLUTAMIC ACID RECEPTOR AGONIST | NIPPON SUISAN KAISHA, LTD. (JP) | 1997-12-10 | — | — | EP | disclosed |
| EP-0469901-B1 | Sulfonamide derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 1994-10-19 | — | — | EP | disclosed |
| US-5189211-A | Thromboxane A2 antagonists | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1993-02-23 | — | — | US | disclosed |
| EP-0469901-A1 | Sulfonamide derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1992-02-05 | — | — | EP | disclosed |